Insiders Voyager Therapeutics, Inc.

Equities

VYGR

US92915B1061

Real-time Estimate Cboe BZX Other stock markets 10:26:24 2024-05-17 am EDT			5-day change	1st Jan Change
8.42 ^USD	-2.43%		+0.12%	+0.12%

May. 14	Wedbush Adjusts Voyager Therapeutics' PT to $8 From $10, Keeps Neutral Rating	MT
May. 13	Transcript : Voyager Therapeutics, Inc., Q1 2024 Earnings Call, May 13, 2024

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Voyager Therapeutics, Inc. Appoints Robin Swartz as Principal Accounting Officer	Apr. 02	CI
Voyager Therapeutics Appoints Toby Ferguson as Chief Medical Officer	Mar. 13	MT
Voyager Therapeutics, Inc. Announces Appointment of Toby Ferguson as Chief Medical Officer, Effective March 25, 2024	Mar. 13	CI
Voyager Therapeutics Announces Appointment of Jacquelyn Fahey Sandell as Chief Legal Officer	23-07-10	CI
Voyager Therapeutics, Inc. Appoints George Scangos as Director and as Member of Science and Technology Committee	23-05-09	CI
Voyager Therapeutics, Inc. Announces Names of Directors Not Standing for Re-Election	23-04-27	CI
Insider Sell: Voyager Therapeutics	23-03-17	MT
Voyager Therapeutics, Inc. Appoints Jude Onyia as Director	23-02-24	CI
Voyager Therapeutics, Inc. Announces Board Changes, Effective April 28, 2023	23-02-23	CI
Voyager Therapeutics, Inc. Appoints Grace E. Colón, Ph.D., to Its Board of Directors, Effective on January 1, 2023	22-12-14	CI
Voyager Therapeutics Names Peter Pfreundschuh Finance Chief	22-09-07	MT
Voyager Therapeutics, Inc. Announces Executive Changes, Effective September 19, 2022	22-09-07	CI
Voyager Therapeutics Appoints Peter Pfreundschuh as CFO, Effective September 19, 2022	22-09-07	CI
Voyager Therapeutics Appoints Catherine J. Mackey, Ph.D. to Its Board of Directors	22-07-28	CI
Voyager Therapeutics, Inc. Announces Executive Changes	22-06-07	CI
Voyager Therapeutics Stock Plunges Thursday After Two Directors Decide Not to Stand for Re-Election	22-04-21	MT
Mark Levin and Steven Paul Requests Voyager Therapeutics Not to Nominate for Re-Election to the Board	22-04-20	CI
Voyager Therapeutics Names Former Biogen R&D Chief Sandrock CEO	22-03-22	DJ
Voyager Therapeutics Appoints Alfred Sandrock as CEO	22-03-22	MT
Voyager Therapeutics, Inc. Announces Executive Changes	22-03-22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Voyager Therapeutics, Inc.

Equities

VYGR

US92915B1061

Insiders

Filters